Clinical trial

Post-marketing Observational Study in Subjects With Rheumatoid Arthritis

NCT00234884

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2003-09-01

PhaseN/A

Study timeline

Study start (unknown)2003-09-01Date precision: month

Registry last updated2011-09-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

adalimumabBIOLOGICAL

Sponsors & collaborators

Abbottlead sponsor

Mapped research locations

MadridSpain9 BarcelonaSpain7 BrusselsBelgium7 AthensGreece7 ParisFrance5 BerlinGermany4 MarseilleFrance4 LisbonPortugal4 ThessalonikiGreece4 MilanItaly3 LyonFrance3 RomeItaly3

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00234884 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.